|
ACO Name and Location
Genesys PHO, L.L.C.
3495 S. Center Road
Burton, MI 48519
ACO Primary Contact
Wendy Upthegrove
(810) 424-2016
Wendy.Upthegrove@genesyspho.com
Organizational Information
ACO Participants:
ACO Participants | ACO Participant in Joint Venture |
ASCENSION GENESYS HOSPITAL | Y |
ASCENSION MEDICAL GROUP GENESYS | Y |
BEECHER SURGICAL ASSOCIATES PLLC | N |
CHRISTOPHER D TYKOCKI DO PC | N |
Consultants In Ophthalmic & Facial Plastic Surgery | N |
DOUGLAS M IDDINGS PC | N |
David Coriasso | N |
EAR, NOSE, THROAT AND PLASTIC SURGERY ASSOCIATES, P.C. | N |
Edward Lis | N |
FAMILY EYE CARE CTR PC | N |
FENTON FAMILY MEDICINE PC | N |
FLINT GASTROENTEROLOGY ASSOCIATES PC | N |
FLINT NEUROLOGICAL CENTER PC | N |
GENESEE HEMATOLOGY ONCOLOGY PC | N |
GENESEE LUNG ASSOCIATES PC | N |
GENESYS PRACTICE PARTNERS INC | N |
GRAND BLANC VISION CLINIC PC | N |
GREATER MICHIGAN DERMATOLOGY PLLC | N |
HEALTH PARK MEDICAL PRACTICE PC | N |
HEMANT T THAWANI MD PLLC | N |
HENRY HAGENSTEIN DO PC | N |
HOLLY VISION CLINIC PC | N |
INTEGRATED VASCULAR VEIN CENTER OF MICHIGAN PC | N |
JAMES D WALKER II MD MEDICAL ARTS PLLC | N |
JAWAD A SHAH, MD PC | N |
LAPEER MEDICAL ASSOCIATES PC | N |
LAPEER MEDICAL DIAGNOSTICS PC | N |
M AL JABBAN MD PLC | N |
MEI OPERATIONS, PLLC | N |
MICHAEL D ZERAFA PLLC | N |
MICHIGAN GASTROENTEROLOGY CLINIC, PC | N |
MICHIGAN NEUROSURGICAL INSTITUTE, P.C. | N |
ROBERT JAY ZENDLER II DO PC | N |
SILVER LAKE FAMILY PRACTICE LLC | N |
SURESH ANNE MD PC | N |
SURGICAL ASSOCIATES, PLC | N |
SYNTHESIS MEDICAL SPECIALTIES PC | N |
TIMOTHY R HARRIS OD PLC | N |
Tarik Wasfie | N |
UROLOGICAL SERVICES PC | N |
VITREORETINAL SPECIALISTS PLC | N |
WOMENS SPECIALTY ASSOCIATES, P.C. | N |
ACO Governing Body:
Member Last Name | Member First Name | Member Title/Position | Member's Voting Power (Expressed as a percentage) | Membership Type | ACO Participant Legal Business Name and D/B/A, if applicable |
Anderson | John | Board Member | 10 | Community Stakeholder Representative | N/A |
Bedi | Dr. Dhiraj | Secretary | 10 | ACO Participant Representative | Ascension Medical Group Genesys |
Cobb | Jennifer | Hospital | 0 | Other | N/A |
Chrenka | Paul | Board Member | 10 | ACO Participant Representative | Ascension Medical Group Genesys |
Danic | Michael | Hospital | 0 | Other | N/A |
Meyers | Douglas | Hospital | 0 | Other | N/A |
Edgar | William | Hospital | 0 | Other | N/A |
Hanson | Dale | Board Member | 10 | ACO Participant Representative | Ascension Medical Group Genesys |
Haywood | Nancy | Hospital | 0 | Other | N/A |
Duggan | Stephanie | Hospital | 0 | Other | N/A |
Piontkowski | Timothy | Board Member | 10 | ACO Participant Representative | Lapeer Medical Associates PC |
Rao | Sridhar | Vice Chair | 10 | ACO Participant Representative | Ascension Medical Group Genesys |
Rosenbaum | Edward | Other | 10 | Medicare Beneficiary Representative | N/A |
Schaaf | Mark | Treasurer | 10 | ACO Participant Representative | Ascension Medical Group Genesys |
Thomas | Theresa | Board Member | 10 | ACO Participant Representative | Ascension Medical Group Genesys |
Youngs | Kevin | Board Member | 10 | ACO Participant Representative | Ascension Medical Group Genesys |
Key ACO Clinical and Administrative Leadership:
ACO Executive: Randy Kummler
Medical Director: Kevin Youngs, MD
Compliance Officer: Wendy Upthegrove
Quality Assurance/Improvement Officer: Jennifer Humphries
Associated Committees and Committee Leadership:
Committee Name | Committee Leader Name and Position |
Finance, Contracting, Cost Containment Committee | Mark Schaaf, DO, Chair |
Information Systems Committee | Kevin Youngs, MD, Chair |
Medical Services & Quality Committee | Rene Krusinak, DO, Chair Muhammad Aboudan, MD, Co-Chair |
Specialist Quality Improvement & Credentialing Committee | Muhammad Aboudan, MD, Chair |
Preferred Panel Specialist Committee | Theresa Thomas, DO, Chair |
Medical Directors Committee | Kevin Youngs, MD, Chair |
Types of ACO Participants, or Combinations of Participants, that Formed the ACO:
- ACO professionals in a group practice arrangement
- Partnerships or joint venture arrangements between hospitals and ACO professionals
Shared Savings and Losses
Amount of Shared Savings/Losses
- Third Agreement Period
- Performance Year 2022, $1,859,628
- Second Agreement Period
- Performance Year 2021, $3,913,973
- Performance Year 2020, $2,629,258
- Performance Year 2019, $2,460,776
- Performance Year 2018, $5,360,927
- First Agreement Period
- Performance Year 2017, $2,800,594
- Performance Year 2016, $4,540,213
- Performance Year 2015, $2,154,556
Shared Savings Distribution
- Third Agreement Period
- Performance Year 2022
- Proportion invested in infrastructure: 10%
- Proportion invested in redesigned care processes/resources: 0%
- Proportion of distribution to ACO participants: 90%
- Second Agreement Period
- Performance Year 2021
- Proportion invested in infrastructure: 10%
- Proportion invested in redesigned care processes/resources: 0%
- Proportion of distribution to ACO participants: 90%
- Performance Year 2020
- Proportion invested in infrastructure: 10%
- Proportion invested in redesigned care processes/resources: 0%
- Proportion of distribution to ACO participants: 90%
- Performance Year 2019
- Proportion invested in infrastructure: 10%
- Proportion invested in redesigned care processes/resources: 0%
- Proportion of distribution to ACO participants: 90%
- Performance Year 2018
- Proportion invested in infrastructure: 10%
- Proportion invested in redesigned care processes/resources: 0%
- Proportion of distribution to ACO participants: 90%
- First Agreement Period
- Performance Year 2017
- Proportion invested in infrastructure: 10%
- Proportion invested in redesigned care processes/resources: 0%
- Proportion of distribution to ACO participants: 90%
- Performance Year 2016
- Proportion invested in infrastructure: 2.5%
- Proportion invested in redesigned care processes/resources: 0%
- Proportion of distribution to ACO participants: 90%
- Performance Year 2015
- Proportion invested in infrastructure: 4.1%
- Proportion invested in redesigned care processes/resources: 0%
- Proportion of distribution to ACO participants: 90%
Quality Performance Results
2021 Quality Performance Results:
Quality performance results are based on CMS Web Interface
Measure # | Measure Name | Rate | ACO Mean |
CAHPS-1 | Getting Timely Care, Appointments, and Information | 86.31 | 83.96 |
CAHPS-2 | How Well Providers Communicate | 93.44 | 93.47 |
CAHPS-3 | Patient’s Rating of Provider | 92.62 | 92.06 |
CAHPS-4 | Access to Specialists | 77.62 | 77.00 |
CAHPS-5 | Health Promotion and Education | 70.47 | 62.68 |
CAHPS-6 | Shared Decision Making | 62.62 | 60.97 |
CAHPS-7 | Health Status and Functional Status | 74.74 | 73.06 |
CAHPS-8 | Care Coordination | 83.73 | 85.46 |
CAHPS-9 | Courteous and Helpful Office Staff | 92.17 | 91.97 |
CAHPS-11 | Stewardship of Patient Resources | 28.19 | 25.62 |
001 | Diabetes: Hemoglobin A1c (HbA1c) Poor Control2 | 11.90 | 10.71 |
134 | Preventative Care and Screening: Screening for Depression and Follow-up Plan | 72.80 | 76.97 |
236 | Controlling High Blood Pressure | 84.74 | 76.16 |
318 | Falls: Screening for Future Fall Risk | 82.03 | 87.83 |
110 | Preventative Care and Screening: Influenza Immunization | 64.15 | 77.34 |
226 | Preventative Care and Screening: Tobacco Use: Screening and Cessation Intervention | 76.00 | 79.27 |
113 | Colorectal Cancer Screening | 84.79 | 75.32 |
112 | Breast Cancer Screening | 82.66 | 78.07 |
438 | Statin Therapy for the Prevention and Treatment of Cardiovascular Disease | 83.14 | 86.37 |
321 | CAHPS for MIPS | N/A | N/A |
479 | Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for MIPS Groups2 | 0.1601 | 0.1510 |
MCC1 | All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions for ACOs (MCC)2 | 27.36 | 30.97 |
For Previous Years’ Financial and Quality Performance Results, Please Visit data.cms.gov.
|